Overview
Meeting Announcement
The American Academy of Clinical Toxicology and the American Association of Poison Control Centers are pleased to announce that the North American Congress of Clinical Toxicology 2011 and associated pre-meeting functions will be held at the Omni Shoreham Hotel, Wahington DC, September 21-26, 2011.
This annual conference allows an opportunity for physicians, nurses, pharmacists, and scientists from around the world to participate in the sharing of knowledge on a wide variety of issues in clinical toxicology. In addition, there will be multiple original research papers presented, a number of symposia, as well as other traditional and novel continuing education sessions.
General Objectives:
- Identify the acute and/or chronic toxic effects of various drugs, chemicals and biologicals.
- Utilize research data to determine new approaches to the prevention, assessment, and treatment of poisoning victims.
- Compare and contrast approaches to the treatment of poisoned patients.
- Identify the principles of assessing the severity and predicting the outcome of poisonings.
- Define innovations in the responsibilities and functions of poison centers.
- Identify the principles involved in the laboratory evaluation of poisonings.
- Identify the risks and treatment of occupational and environmental hazards to humans.
The 2011 Congress
The 2011 Congress will offer multiple clinical toxicology symposia, presentation of original research as posters and platforms, and scheduled interest and committee group meetings. Selected topics include:
- Receptor physiology and analytical aspects of synthetic cannabinoids and other synthetic congeners
- Teenage substance abuse
- Management of hazardous material (HazMat) disasters
- Acute liver failure and transplantation in the poisoned patient
- Complementary and alternative medicine related poisonings
- Evidence-based clinical toxicology practices
- Radiation toxicity
- Animals as sentinels of human exposures
NACCT Opening Day
Keynote Presentation
Toxicology and the Regulator: Local, State and Federal Perspectives
Speaker: Dr. Joshua M. Sharfstein, M.D.
Dr. Joshua M. Sharfstein was appointed by Governor Martin O'Malley as Secretary of the Maryland Department of Health and Mental Hygiene in January 2011.
In March 2009, President Obama appointed Dr. Sharfstein to serve as the Principal Deputy Commissioner of the U.S. Food and Drug Administration, the agency's second highest-ranking position. He served as the Acting Commissioner from March 2009 through May 2009 and as Principal Deputy Commissioner through January 2011.
From December 2005 through March 2009, Dr. Sharfstein served as the Commissioner of Health for the City of Baltimore, Maryland. In this position, he led efforts to expand literacy efforts in pediatric primary care, facilitate the transition to Medicare Part D for disabled adults, engage college students in public health activities, increase influenza vaccination of healthcare workers, and expand access to effective treatment for opioid addiction. Under his leadership, the Baltimore Health Department and its affiliated agencies have won multiple national awards for innovative programs, and in 2008, Dr. Sharfstein was named Public Official of the Year by Governing Magazine.
From July 2001 to December 2005, Dr. Sharfstein served as minority professional staff of the Government Reform Committee of the U.S. House of Representatives for Congressman Henry A. Waxman. Dr. Sharfstein is a 1991 graduate of Harvard College, a 1996 graduate of Harvard Medical School, a 1999 graduate of the combined residency program in pediatrics at Boston Children's Hospital and Boston Medical Center, and a 2001 graduate of the fellowship in general pediatrics at the Boston University School of Medicine.
Special Opportunities for 2011
- Hosted by the AACT Acute & Intensive Care SIG: Use of a Simulation Center for Clinical Toxicology Training
Using a simulation mannequin, meeting attendees will be given the opportunity to observe and/or participate
in using a simulation. An experienced technologist from Medical Education Technologies, Inc. will be
on-site to demonstrate the use of a simulator in clinical toxicology education. The simulation center will be open throughout the meeting. The Simulation Center will be available:
| Friday, September 23rd: |
3:30 pm to 4:30 pm
4:30 pm to 5:30 pm |
| Saturday, September 24th: |
11:00 am to 12:00 pm
12:00 pm to 1:00 pm
2:30 pm to 3:30 pm
3:30 pm to 4:30 pm |
| Sunday, September 25th: |
4:00 pm to 5:00 pm
5:00 pm to 6:00 pm |
ACPE Program Number: 0225-9999-11-208-L04-P / 1.0 credit
Posters featuring toxicology history, made available by the Society of Toxicology, will be on display.
- Lifelong Learning and Self Assessment Course
Monday • September 26th • 11:00 am - 1:00 pm
The American Board of Medical Specialties (ABMS) Medical Toxicology Sub-board facilitates continuous learning by identifying a set of Lifelong Learning and Self-Assessment (LLSA) readings every other year to guide diplomates in self-study of seminal Medical Toxicology literature. The AACT/ACMT LLSA Course provides a dynamic and comprehensive review of these articles, as well as the ability to take the ABMS LLSA examination.
Corporate Sponsors
A special thank you to the following companies:
- McNeil Specialty Consumer Pharmaceuticals
- BTG International, Inc.
- Cumberland Pharmaceuticals
Internet Café and wireless Internet access throughout all sessions.
Online Library
The Online Library is a convenient, easy-to-access format that is available from anywhere on a 24/7 basis.
The Library Features:
- Search by conference name, presentation subject or speaker.
- Download the presentation audio to your mobile media player.
- Take notes during the presentations and store them for later reference.
- Plus much more…
Conference Registrants
As a conference registrant, you have complimentary access to the recorded presentations from the conference sessions for which you registered. Approximately 3 weeks after the conference, you will receive an email notifying you that the actual audio presentation recorded at the live conference and PowerPoint slides are available for access in the Online Library.
Conference Program
Wednesday, September 21 | Thursday, September 22 | Friday, September 23 | Saturday, September 24 | Sunday, September 25 | Monday, September 26
AACT Pre-Meeting Symposium
Wednesday • September 21, 2011
Reducing the Harm Caused by Abused Drugs:
Putting the Science into Public Policy
Toxicologists, while well versed in the diagnosis and treatment of a wide variety of poisonings, often lack an understanding of the legal system and may not be active in public health approaches to reduce the health risks from abused drugs. In addition, there is a disconnect between regulatory initiatives and public health outcomes. This symposium will provide information on the scientific aspects of, and the public policy approach towards, controls for the drugs most used in society (alcohol, nicotine, caffeine, opioids, and marijuana). This symposium's content will place existing regulations in a public health harm reduction model.
Objectives
At the end of the Pre-Meeting Symposium, the learner will be able to:
- Describe the societal effects of the prohibition.
- Understand how a public health model can be applied to drug policy to improved community health.
- Describe methods to bring marginalized individuals into public health and primary care.
- Understand the public health benefits of supervised injection facilities.
- Understand the history of prohibition and its repeal.
- Describe the public health benefits of a regulated model of alcohol consumption.
- Understand the public health implications of tobacco control.
- Describe the international framework convention on tobacco control.
- Describe the challenges in developing vaccines against a toxin.
- Understand the role of nicotine vaccines in smoking cessation.
- Understand the scientific evidence that describe adverse health effects of highly caffeinated alcohol drinks.
- Explain how the FDA was able to regulate highly caffeinated alcohol drinks.
- Describe the potential medical benefits of marijuana.
- Understand the evidence that compares the clinical effects of marijuana with pharmaceuticals.
- Describe the Netherlands' model of marijuana regulation.
- Compare and contrast the health effects of marijuana in regulated and unregulated societies
Moderators:
Robert S. Hoffman, MD, FAACT, FACMT, FRCP Edin
Director, NYC Poison Center
Associate Professor of Emergency Medicine and Medicine
New York University School of Medicine
Attending Physician, Bellevue Hospital Center |
Barbara Kirrane, MD, FAACT
Assistant Professor, Emergency Medicine
Yale University
New Haven, Connecticut |
Topics to be Covered:
- Welcome and Introduction: Models of Control; Prohibition, Legalization, Restriction, Medicalization
Robert S. Hoffman, MD, FAACT, FACMT, FRCP Edin
- The Regulation of Illicit Drugs: A Public Health Approach
Mark Haden, MSW; Clinical Supervisor, Addiction Services, Vancouver Coastal Health
- North America's First Supervised Injection Facility - Evidence of Harm Reduction
Brandon Marshal, PhD; Canadian Institutes of Health Research Fellowship Awardee, IAS/NIDA Fellowship in Encouraging HIV and Drug Use Research Recipient, Postdoctoral Fellow, Department of Epidemiology, Columbia University Mailman School of Public Health
- Alcohol and the 21st Amendment: Regulation vs Prohibition
Marc Sorini; Partner, McDermott Will & Emery LLP
- Highly Caffeinated Alcohol Drinks: is There a Proven Risk
Kirk Cumpston, DO; Medical Director, Virginia
Poison Center; Assistant Professor, Division of Clinical Toxicology, Department of Emergency Medicine, Virginia Commonwealth University
- Tobacco Addiction Science: Implications for International Regulation Under the
Framework Convention on Tobacco Control
Jack Henningfield; Health Policy Pinney Associates,
Professor, Adjunct, and Director, Innovators Awards Program Dept. of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine
- Novel Approaches to Smoking Cessation: Nicotine Vaccines
Dan Keyler, PharmD; Clinical Professor, Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy
- An Evidence-Based Look at Medical Marijuana
Robert S. Hoffman, MD, FAACT, FACMT, FRCP Edin;
Director, NYC Poison Center Associate Professor of Emergency Medicine and Medicine New York University School of Medicine Attending Physician, Bellevue Hospital Center
- Marijuana Decriminalization: Walking the High Wire Between the Legislative Framework and Public Health
Irma de Vries, MD; Associate Director, Dutch National Poisons Information Center
ACMT Pre-Meeting Symposium
Thursday • September 22, 2011
Inside the Beltway and Beyond: The Intersection of Medical Toxicology and the Federal Government
Government regulations and initiatives have a powerful impact on medical toxicology. From pharmaco-vigilance to public health crises, it is essential that toxicologists and poison information specialists remain current on the toxicologic issues facing the federal government, as well as their effects on clinical practice. This symposium highlights the intersection and interactions between the broad scope of human toxicology and U.S. government agencies. Experts from the Centers for Disease Control and Prevention, Department of Defense, Department of Homeland Security, Drug Enforcement Agency, Environmental Protection Agency, Federal Bureau of Investigation, Food and Drug Administration, and White House will discuss exciting areas of public health importance for their agency that are directly relevant to practicing toxicologists. This is a unique opportunity for an "insider" look at the role of toxicology at the federal level.
Objectives
At the end of the Pre-meeting Symposium, the learner will be able to:
- Describe an overarching national strategy for chemical preparedness.
- Describe the role of toxicologists working within the federal government.
- Describe the types of toxicology cases that the FBI Laboratory receives.
- Discuss several examples of the types of specimens the FBI Laboratory Toxicology Subunit analyzes.
- Briefly summarize current management of casualties of the four major classes of chemical agents of potential use in warfare or terrorism.
- Discuss next-generation products in advanced development within the Departments of Defense and of Health and Human Services to counter these threats.
- Discuss and understand the role of the federal government and the clinical toxicology community in domestic and international outbreak investigation.
- Discuss the brief history of recent toxic outbreaks and investigations at the CDC in which clinical toxicologists played an important role.
- Describe the federal executive policy process and connection to health response activities in disasters.
- Understand chemical preparedness and response national capabilities.
- Discuss the variability in drug response in terms of efficacy and adverse events.
- Describe initiatives in personalized medicine such as genomic biomarkers.
- Discuss how FDA's Sentinel Initiative is responding to the Congressional mandate in the FDA Amendments Act of 2007 to develop an electronic system for post-marketing risk identification and analysis of medical product safety issues.
- Describe the scientific methodologies and data infrastructure of FDA's pilot programs for active medical product surveillance.
- Describe the federal government's response to chemical, biological, radiation, and oil release.
- Describe the EPA Federal On Scene Coordinator's role and responsibilities.
- Discuss the recent trends in pharmaceutical drug diversion.
- Discuss the recent trends in illicit and designer drugs of abuse.
Thursday • September 22, 2011
Moderators:
Louise Kao, MD
Director, Medical Toxicology Fellowship
Associate Professor
Clinical Emergency Medicine
Indiana University School of Medicine |
Michele Burns Ewald, MD
Medical Director:
MA/RI Poison Control Center
Director, Medical Toxicology Fellowship
Assistant Professor of Pediatrics
Harvard Medical School |
Kavita Babu, MD
Assistant Professor
Division of Medical Toxicology
Department of Emergency Medicine
The Alpert Medical School
Brown University |
Topics to be Covered:
- Introduction and Opening Remarks
Lewis Nelson, MD, FAACT, FACMT; President, American College of Medical Toxicology; Director, Fellowship in Medical Toxicology, Associate Professor of Emergency Medicine, New York University School of Medicine
- Enhancing Preparedness Against Chemical Threats
Mark A Kirk, MD, FACMT; Special Advisor for Chemical Defense and Medical Toxicology, Office of Health Affairs, Department of Homeland Security; Associate Professor, Department of Emergency Medicine, University of Virginia
- The FBI Laboratory and Complicated Forensics
Cynthia L. Morris-Kukoski, PharmD, DABAT; Forensic Examiner, Federal Bureau of Investigation Toxicology Laboratory
- Updates From the Medical Chemical Defense Pipeline
Jonathan Newmark, MD, FAAN; Deputy Joint Program Executive Officer, Medical Systems Joint
Program Executive Office for Chemical/Biological Defense, US Department of Defense, Falls Church, Virginia; Adjunct Professor of Neurology, F. Edward Hébert School of Medicine Uniformed Services University of the Health Sciences; Consultant to the Surgeon General, Chemical Casualty Care
- Toxic Outbreaks and Investigations
Joshua Schier, MD, FACMT; Medical Toxicologist/ Epidemiologist, Centers for Disease
Control and Prevention; Associate Director, Emory/ CDC Medical Toxicology Fellowship; Assistant
Professor of Emergency Medicine, Emory University School of Medicine
- Health Preparedness Priorities: Intersection of Policy and Practice
David "Marco" Marcozzi, MD, MHS-CL, FACEP;
Director, All-Hazards Medical Preparedness Policy, White House National Security Staff
- Pharmacogenomics and Personalized Medicine
Lawrence J. Lesko, PhD, FCP; Director, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration
- The Sentinel Initiative and Pharmacovigilance
Monika Houstoun, PharmD, BCPS; Office of Surveillance and Epidemiology, Food and Drug Administration
- EPA Emergency Response and Removal: From Oil to Anthrax
Charlie Fitzsimmons; Federal On-Scene Coordinator, USEPA Region III
Srihari Tella, PhD; Unit Chief, Drug and Chemical Control Unit, Drug and Chemical Evaluation Section, Office of Diversion Control, Drug Enforcement Administration
AAPCC Public Education Track
Poison center educators, health educators, childhood injury prevention specialists, Certified Health Education Specialist (CHES)-eligible participants
Attendees of this track will have the opportunity to learn about best practices in poison prevention education and evidenced-based strategies targeted at specific audiences. Several sessions will offer interactive web experiences. This track runs concurrently with the clinical toxicology education sessions of the main congress.
Application has been made to the National Commission for Health Education Credentialing, Inc. (NCHEC) for CHES Category I continuing education contact hours (CECH).
Friday – September 23, 2011
Topics Covered:
- Needs assessment workshop for educators
Lauren M. Schwartz, MPH, New York City Poison Control Center
Melissa Heinen, RN, BSN, MPH, CPH, Salus Consulting
Al Bronstein, MD, FACEP, Rocky Mountain Poison and Drug Center
- How does public health connect with poison prevention?
Andrea Gielen,ScD, Johns Hopkins Bloomberg
School of Public Health
- Web-based technology for public health messaging
Najja Howard, MPS, BA, Illinois Poison Center
Saturday – September 24, 2011
Topics Covered:
- Time management – get more done
Lee Livermore, BA, Upstate New York Poison Center
Holly Wells, Education Manager, American Association of Poison Control Centers
JoAnn Chambers-Emerson, RN, BSN, CSPI, Florida Poison Information Center
- PEC sub-committee meetings
Sub-committee chairs
- Advancing the mission of poison centers through advocacy
Amy Hanoian-Fontana, BA, MA, EMT-B, Connecticut Poison Control Center
Sunday – September 25, 2011
Topics Covered:
- HRSA – Poison help campaign updates
Elisa H. Gladstone, MPH, Director, Poison Control Program, Health Resources and Services Administration
Moderator-Amy Hanoian-Fontana, BA, MA, EMT-B,
Connecticut Poison Control Center
- Using interactive games to educate
Christina DiRienzo, BA, Palmetto Poison Center
- A look at calls to the poison help line
Evelyn Waring, RN, BSN, CSPI, Virginia Poison Center
Liz Barta, BS, CHES, Arizona Poison & Drug Information Center
Monday – September 26, 2011
Topics Covered:
- Everything you always wanted to know, but didn't know who to ask
Christina DiRienzo, BA, Palmetto Poison Center
- Brainstorm session for abstract and poster ideas
Marty Malheiro, MS, MCHES, Utah Poison Control Center
- Open planning meeting for NACCT 2012
Mike Yudizky, BS, North Texas Poison Center
Marty Malheiro, MS, MCHES, Utah Poison Control Center
- PEC steering committee meeting
PEC Co-Chairs: Rebecca L. Miller, MPH, BSN, CSPI, CHES,
Northern New England Poison Center and Ronica Farrar, EMT-P, Texas Panhandle Poison Center
Tentative Schedule and Continuing Education Credit
- The following schedule is tentative and subject to change.
| |
|
|
Credit Hours* |
| Session |
|
ACPE Program Manager |
RPh |
MD |
RN |
Wednesday, September 21, 2011
| 8:00 am – 5:00 pm |
AACT Pre-Meeting Symposium: Reducing the Harm Caused by Abused Drugs |
0225-9999-11-200-L04-P |
6.5 |
6.5 |
6.5 |
Back to Top
Thursday, September 22, 2011
| 8:00 am – 5:00 pm |
ACMT Pre-Meeting Symposium: Inside the Beltway and Beyond |
0225-9999-11-201-L04-P |
6.5 |
6.5 |
6.5 |
| 1:00 pm – 4:00 pm |
Exhibit/Poster Session I Set-Up |
|
|
|
|
| 5:15 pm – 7:15 pm |
ACMT Clinical Pathophysiology
Competition (CPC) |
0225-9999-11-202-L04-P |
2.0 |
2.0 |
2.0 |
Back to Top
Friday, September 23, 2011
American Association of Poison Control Centers Symposium
| 7:30 am – 9:00 am |
Keynote Presentation and Breakfast |
0225-9999-11-203-L04-P |
1.0 |
1.0 |
1.0 |
| 9:00 am - 4:00 pm |
Exhibits/Posters Session I |
|
|
|
|
| 9:00 am – 10:00 am |
Authors with Posters |
|
|
|
|
| 10:00 am – 12:00 pm |
AAPCC Scientific Symposium: The Intersection of Public Health and Poison Centers |
0225-9999-11-204-L04-P |
2.0 |
2.0 |
2.0 |
| 12:00 pm – 1:00 pm |
Lunch Break |
|
|
|
|
| 1:00 pm – 3:00 pm |
Platform Session 1 |
0225-9999-11-205-L04-P |
2.0 |
2.0 |
2.0 |
| 3:00 pm – 3:30 pm |
Break |
|
|
|
|
| 3:30 pm - 5:30 pm |
AAPCC SPI Poison Center Best Practice Symposium |
0225-9999-11-206-L04-P |
2.0 |
2.0 |
2.0 |
| 3:30 pm - 5:30 pm |
Articles You May Have Missed |
0225-9999-11-207-L04-P |
2.0 |
2.0 |
2.0 |
| 3:30 pm - 5:30 pm |
Trainees Research Symposium |
0225-9999-11-240-L04-P |
2.0 |
2.0 |
2.0 |
| 6:00 pm – 7:00 pm |
Opening Reception |
|
|
|
|
| 7:00 pm – 9:00 pm |
SPI Awards/Quiz Bowl |
|
|
|
|
Back to Top
Saturday, September 24, 2011
Pediatric Environmental Health & Toxicology
| 8:00 am – 10:00 am |
AACT Scientific Symposium: Cannabinoid Receptor Agonists and Antagonists |
0225-9999-11-210-L04-P |
2.0 |
2.0 |
2.0 |
| 9:00 am – 4:00 pm |
Exhibits/Posters Session II |
|
|
|
|
| 10:00 am – 11:00 am |
Authors with Posters |
|
|
|
|
| 11:00 am – 12:00 pm |
Platform Session II (Pediatrics) |
0225-9999-11-211-L04-P |
1.0 |
1.0 |
1.0 |
| 11:00 am – 12:00 pm |
AACT: Forensic SIG NAS Report:
Regulatory Changes in Forensic Toxicology |
0225-9999-11-212-L04-P |
1.0 |
1.0 |
1.0 |
| 11:00 am – 1:00 pm |
APAMT Symposium: Complimentary and
Alternative Medicine Related Poisonings in Asia |
0225-9999-11-213-L04-P |
2.0 |
2.0 |
2.0 |
| 12:00 pm – 1:30 pm |
Lunch Break |
|
|
|
|
| 12:00 pm - 1:30 pm |
ACMT Fellows-in-Training Roundtable |
0225-9999-11-214-L04-P |
|
1.5 |
|
| 1:00 pm - 2:30 pm |
AACT Pediatrics SIG: Teens, 'Tudes and Tests: Teen Use and Drug Testing |
0225-9999-11-215-L04-P |
1.5 |
1.5 |
1.5 |
| 1:30 pm - 3:30 pm |
CAPCC Symposium: Risk Assessment
in Acetaminophen Overdose |
0225-9999-11-216-L04-P |
2.0 |
2.0 |
2.0 |
| 1:30 pm - 3:30 pm |
ACMT Practice Symposium |
0225-9999-11-217-L04-P |
2.0 |
2.0 |
2.0 |
| 2:45 pm - 6:00 pm |
AACT Pediatric Environmental Health and
Translational Research Symposium |
0225-9999-11-218-L04-P |
3.0 |
3.0 |
3.0 |
| 3:30 pm - 4:00 pm |
Break |
|
|
|
|
| 4:00 pm – 5:00 pm |
AAPCC: Advancing the Mission of Poison
Centers Through Advocacy |
0225-9999-11-219-L04-P |
1.0 |
1.0 |
1.0 |
| 4:00 pm – 5:00 pm |
AAPCC Veterinary Symposium: Animals as Sentinels of Human Exposures |
0225-9999-11-220-L04-P |
1.0 |
1.0 |
1.0 |
| 4:00 pm – 6:00 pm |
ABAT Symposium: Drugs of Tomorrow
& Challenges of Today |
0225-9999-11-221-L04-P |
2.0 |
2.0 |
2.0 |
Back to Top
Sunday, September 25, 2011
| 8:00 am – 10:00 am |
ACMT Scientific Symposium: Liver
Failure/Transplantation |
0225-9999-11-222-L04-P |
2.0 |
2.0 |
2.0 |
| 9:00 am – 4:00 pm |
Exhibits/Poster Session III |
|
|
|
|
| 10:00 am – 11:00 am |
Authors with Posters |
|
|
|
|
| 11:00 am – 12:00 pm |
AACT Career Achievement Lectureship: Junk Science |
0225-9999-11-223-L04-P |
1.0 |
1.0 |
1.0 |
| 12:00 pm – 1:30 pm |
Lunch Break |
|
|
|
|
| 12:00 pm – 1:30 pm |
ACMT Fellows-in-Training Luncheon |
0225-9999-11-224-L04-P |
|
1.5 |
|
| 1:30 pm – 2:30 pm |
Platform Session III |
0225-9999-11-225-L04-P |
1.0 |
1.0 |
1.0 |
| 1:30 pm – 3:30 pm |
AACT Acute and Intensive Care Symposium: Toxicology Dilemmas & Controversies |
0225-9999-11-227-L04-P |
2.0 |
2.0 |
2.0 |
| 1:30 pm – 3:30 pm |
AAPCC SPI Clinical Practice Symposium Medical Management of Hazardous Materials Incidents |
0225-9999-11-228-L04-P |
2.0 |
2.0 |
2.0 |
| 2:30 pm – 3:30 pm |
Platform Session IV |
0225-9999-11-226-L04-P |
1.0 |
1.0 |
1.0 |
| 3:30 pm – 4:00 pm |
Break |
|
|
|
|
| 4:00 pm – 5:00 pm |
AACT Envenomation SIG: Envenomations by Land, Sea, or Sky |
0225-9999-11-229-L04-P |
1.0 |
1.0 |
1.0 |
| 4:00 pm – 5:00 pm |
ACMT Ellenhorn Symposium |
0225-9999-11-230-L04-P |
1.0 |
1.0 |
1.0 |
| 4:00 pm – 6:00 pm |
AACT Radiation and WMD SIG Symposium |
0225-9999-11-231-L04-P |
2.0 |
2.0 |
2.0 |
| 5:00 pm – 6:00 p.m |
AACT Herbal SIG |
0225-9999-11-232-L04-P |
1.0 |
1.0 |
1.0 |
| 5:00 pm – 6:00 p.m |
AACT Year in Toxicology |
0225-9999-11-233-L04-P |
1.0 |
1.0 |
1.0 |
| 7:00 pm – 9:00 pm |
Toxicology History Society Symposium |
0225-9999-11-209-L04-P |
2.0 |
2.0 |
2.0 |
Back to Top
Monday, September 26, 2011
| 7:00 am – 11:00 pm |
Exhibits/Posters Session IV |
|
|
|
|
| 8:00 am – 10:00 am |
EAPCCT Symposium: The Changing Face of Recreational Drug Use in Europe |
0225-9999-11-234-L04-P |
2.0 |
2.0 |
2.0 |
| 8:00 am – 10:00 am |
WHO/IPCS Symposium: Investigation of
Disease Outbreaks of Uncertain Etiology |
0225-9999-11-235-L04-P |
2.0 |
2.0 |
2.0 |
| 10:00 am – 11:00 am |
Authors/Posters |
|
|
|
|
| 11:00 am - 12:00 pm |
NLM Symposium: Online Government Resources to Support Clinical Toxicology |
0225-9999-11-236-L04-P |
1.0 |
1.0 |
1.0 |
| 11:00 am - 1:00 pm |
AAPCC SPI Roundtable: What You Really Want to Know, But Are Afraid to Ask |
0225-9999-11-237-L04-P |
2.0 |
2.0 |
2.0 |
| 11:00 am - 1:00 pm |
AACT/ACMT LLSA Course |
0225-9999-11-238-L04-P |
3.0 |
3.0 |
3.0 |
| 12:00 pm – 1:00 pm |
AACT Occupational Environmental SIG:
The Tennessee Fly Ash Disaster |
0225-9999-11-239-L04-P |
1.0 |
1.0 |
1.0 |
| |
|
|
Rph |
MD |
RN |
| |
Maximum Hours for Total Conference |
|
47.5 |
49.0 |
47.5* |
**Application for nursing credits has been submitted to the California Board of Nursing. Credit hours are preliminary, and subject to final approval.
*The AACT reserves the right to adjust the maximum number of hours available pending changes in the program schedule.
AACT = American Academy of Clinical Toxicology
AAPCC = American Association of Poison Control Centers
ABAT = American Board of Applied Toxicology
ACMT = American College of Medical Toxicology
APAMT = Asia Pacifi c Association of Medical Toxicology
CAPCC = Canadian Association of Poison Control Centres
EAPCCT = European Association of Poisons Centres and Clinical Toxicologists
SPI = Specialist in Poison Information
SIG = Special Interest Group
IPCS = International Programme for Chemical Safety
NLM = National Library of Medicine
SPI = Specialist in Poison Information
WMD = Weapons of Mass Destruction
Back to Top